2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Part 1: Up to 70% of people with MS suffer from cognitive dysfunction, which can have a profound impact on everyday life. Treatment can include cognitive rehabilitation, exercise and medication. This symposium will provide an evidence-based perspective on treatment approaches …
Level of Information Archives:
Driving Discovery in MS: The Power of Research Integrated Care
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Research is the driving force behind progress in multiple sclerosis, turning scientific discoveries into meaningful advances in patient care and treatment. This two-hour session will explore how clinical research is integrated into patient-centered MS practice and highlight the contributions …
Continue reading “Driving Discovery in MS: The Power of Research Integrated Care”
John Whitaker Lecture-The Illusion of Equivalence? Generic and Biosimilar Disease-Modifying Therapies in Multiple Sclerosis
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Multiple sclerosis (MS) represents a spectrum of demyelinating presentations with varying degrees of inflammatory activity and symptom expression, affecting nearly one million individuals in the U.S. The use of Food and Drug Administration (FDA)-approved disease-modifying therapies (DMTs) aim to reduce risk for clinical …
Emerging and Established Biomarkers in Neuroinflammatory Disease
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE The biomarker field is advancing quickly, and aside from mass biomarker arrays analyzed by AI, single biomarkers have been established to help in predicting disease course and monitoring response to therapy. The role of NfL is by far the most advanced in aligning with …
Continue reading “Emerging and Established Biomarkers in Neuroinflammatory Disease”
Stronger You, Stronger MS Care
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Delivering exceptional MS care requires purpose driven, adaptable, and engaged teams. This interactive course explores how workforce wellbeing can be integrated into leadership and professional development. Using evidence-based frameworks and practical tools, participants will learn strategies to foster meaning …
Advances in CSF Biomarkers for Multiple Sclerosis
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE The brain’s ‘soup’ or CSF is rich with information that may exude from processes within the CNS. It is once again an integral part of the new diagnostic criteria, but an alternative assay to the usual and tedious detection of CSF-specific IgG oligoclonal …
Continue reading “Advances in CSF Biomarkers for Multiple Sclerosis”
Spinal Cord Variants: Special Considerations in MS Diagnosis and Treatment
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This scientific session will examine emerging concepts in spinal cord (SC)-focused MS and demyelinating disease, highlighting how advances in pathology, imaging, and mechanistic understanding are reshaping traditional models of central nervous system demyelination. Particular attention will be given to the SC as a critical …
Continue reading “Spinal Cord Variants: Special Considerations in MS Diagnosis and Treatment”
Whitaker Platform Session
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This platform session will feature cutting-edge investigations from emerging and established researchers, highlighting novel insights into the biological mechanisms, biomarkers, and clinical manifestations of multiple sclerosis (MS). Presentations will explore accelerated aging in MS through neuroimaging and proteomic approaches, …
The June Halper Memorial Lecture: The Journey is the Destination: 40 Years of CMSC, 40 Years of MS Neuropsychiatry
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …
OCT Across the Spectrum of Demyelinating Disease
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE OCT (optical coherence tomography) has significantly advanced the clinical practice of neuro-ophthalmology, including the care of patients with demyelinating disease. OCT is a non-invasive, reliable, financially accessible technique for visualizing structures in the eye including the retinal nerve fiber layer (RNFL) and ganglion cell-inner …
Continue reading “OCT Across the Spectrum of Demyelinating Disease”